Reply to thread

I think this article is correct-  Actavis can't really afford Allergan-  Actavis has many synergies with Salix and that deal is what they really want.  Because of the outcry of nonsupport of an all-cash deal between Allergan and Salix-  I think a deal between us and Salix is pretty much off the table.  Valeant only gets us if they succeed in replacing our Board of Directors.


http://www.fool.com/investing/general/2014/10/09/actavis-plc-and-valeant-pharmaceuticals-inc-battle.aspx